Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075214 · ClinicalTrials.gov registry record · NA
Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
A NA study of Opioid Use Disorder and Opioid Withdrawal, sponsored by Spark Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04075214 is a NA study of Opioid Use Disorder and Opioid Withdrawal that has completed, run by Spark Biomedical. The registered enrollment target is 35 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04075214, a NA study of Opioid Use Disorder and Opioid Withdrawal, has completed, sponsored by Spark Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical performance data for transcutaneous auricular neurostimulation (tAN) as a method to aid in the reduction of symptoms associated with opioid withdrawal in order to support clinical substantial equivalence to a predicate device.
Conditions Studied
Interventions
- DEVICE transcutaneous auricular neurostimulation (tAN)
Study Locations (1)
Texas
- Recovery Unplugged - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2020-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04075214
The ClinicalTrials.gov registry entry for NCT04075214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Spark Biomedical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which transcutaneous auricular neurostimulation (tAN) is the first listed.
NCT04075214 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04075214 about?
NCT04075214 is a clinical study titled "Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal". Clinical performance data for transcutaneous auricular neurostimulation (tAN) as a method to aid in the reduction of symptoms associated with opioid withdrawal in order to support clinical substantial equivalence to a predicate device.
What is the current status of trial NCT04075214?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-11-19. Estimated completion is 2020-12-14.
What conditions does trial NCT04075214 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Withdrawal.
What interventions are being tested in trial NCT04075214?
The interventions under investigation include: transcutaneous auricular neurostimulation (tAN) (DEVICE).
Who is sponsoring clinical trial NCT04075214?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04075214 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.